Related Experiment Video
Updated: Apr 17, 2026

Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
Glycosylation profiles determine extravasation and disease-targeting properties of armed antibodies
Dario Venetz1, Christian Hess1, Chia-wei Lin2
1Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, and.
Abstract:
The ability of antibodies to extravasate out of blood vessels is critical for therapeutic activity, because molecular targets for most diseases are located outside of the endothelial lining. By performing detailed biodistribution studies with a novel IL9-armed cancer-specific antibody, we identified a clear correlation between N-linked glycan structures and tumor-targeting efficiencies. Site-specific glycan analysis provided a detailed view of the glycan microheterogeneity present on the IL9 portion of the recombinant protein. Nonsialylated glycan structures have a negative impact on disease-homing activity, highlighting the importance of glycosylation control and characterization during process development.
Insights
Antibody extravasation is key for cancer therapy. This study found that specific N-linked glycan structures on antibodies significantly impact tumor targeting efficiency, emphasizing glycosylation control in drug development.
Area of Science:
- Biotechnology
- Immunology
- Glycobiology
Background:
- Antibody extravasation is crucial for reaching molecular targets in diseases, as these targets are often located outside blood vessels.
- Understanding the factors influencing antibody biodistribution is essential for developing effective antibody-based therapeutics.
Purpose of the Study:
- To investigate the correlation between N-linked glycan structures and the tumor-targeting efficiency of a novel IL9-armed cancer-specific antibody.
- To analyze the glycan microheterogeneity on the IL9 portion of the recombinant antibody.
- To determine the impact of specific glycan structures on antibody homing activity.
Main Methods:
- Detailed biodistribution studies were performed using a novel IL9-armed cancer-specific antibody.
- Site-specific glycan analysis was employed to characterize the N-linked glycan structures.
- Correlation analysis was conducted between glycan structures and tumor-targeting efficiencies.
Main Results:
- A clear correlation was identified between N-linked glycan structures and tumor-targeting efficiencies.
- Site-specific glycan analysis revealed significant glycan microheterogeneity on the IL9 portion of the antibody.
- Nonsialylated glycan structures were found to negatively impact disease-homing activity.
Conclusions:
- N-linked glycan structure is a critical determinant of antibody tumor-targeting efficiency.
- Glycosylation control and thorough characterization are vital during the process development of antibody-based therapeutics.
- Minimizing nonsialylated glycans may enhance the therapeutic efficacy of antibodies by improving disease homing.
Related Concept Videos
Proteoglycans
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Protein Glycosylation
Glycosylation occurs in...

